Akebia Therapeutics
AKBA
AKBA
121 hedge funds and large institutions have $129M invested in Akebia Therapeutics in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 19 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.83% more ownership
Funds ownership: 28.26% → 31.1% (+2.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
56% less call options, than puts
Call options by funds: $335K | Put options by funds: $769K
Holders
121
Holding in Top 10
1
Calls
$335K
Puts
$769K
Top Buyers
| 1 | +$5.46M | |
| 2 | +$2.63M | |
| 3 | +$1.55M | |
| 4 |
Morgan Stanley
New York
|
+$1.33M |
| 5 |
Goldman Sachs
New York
|
+$982K |
Top Sellers
| 1 | -$1.53M | |
| 2 | -$252K | |
| 3 | -$189K | |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$188K |
| 5 |
Squarepoint
New York
|
-$185K |